儿童输注夫西地酸钠致静脉炎的风险管理研究进展  

Research progress on risk management of phlebitis caused by sodium fusidate infusion in children

作　　者：王娟 陈艳华 王燕 WANG Juan;CHEN Yanhua;WANG Yan(Department of Pharmacy,Wuxi Children's Hospital,Wuxi 214023,China)

机构地区：[1]无锡市儿童医院药学部,江苏无锡214023

出　　处：《药物评价研究》2021年第10期2274-2279,共6页Drug Evaluation Research

摘　　要：儿童输注夫西地酸钠在临床上常用于敏感菌的抗感染治疗,但输注夫西地酸钠可引发静脉炎,静脉输液外渗甚至引起组织坏死,增加了儿童的用药风险。儿童输注夫西地酸钠致静脉炎与多种因素有关,通过给予相应的措施可减少静脉炎的发生,从儿童输注夫西地酸钠致静脉炎的识别与判断、风险点分析、预防措施、治疗措施方面进行综述,以期为儿童输注夫西地酸钠的安全使用提供参考。Sodium fusidate infusion is often used clinically for the anti-infective treatment of sensitive bacteria in children,but sodium fusidate infusion can cause phlebitis,leakage and even tissue necrosis,which increases the risk of children's medication.Phlebitis caused by sodium fusidate infusion in children is related to many factors,the occurrence of which can be reduced by giving corresponding measures.This article reviews the identification and judgment,risk analysis,preventive measures,and treatment measures of phlebitis caused by sodium fusidate infusion in children,in order to provide references for the safe use of sodium fusidate infusion in children.

关 键 词：夫西地酸钠 儿童用药 静脉炎 静脉输液外渗 用药风险 

分 类 号：R969.3[医药卫生—药理学]